Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma.
Hotte SJ, Bjarnason GA, Heng DY, Jewett MA, Kapoor A, Kollmannsberger C, Maroun J, Mayhew LA, North S, Reaume MN, Ruether JD, Soulieres D, Venner PM, Winquist EW, Wood L, Yong JH, Saad F. Hotte SJ, et al. Curr Oncol. 2011 Oct;18 Suppl 2(Suppl 2):S11-9. doi: 10.3747/co.v18is2.941. Curr Oncol. 2011. PMID: 21969807 Free PMC article.
Localized prostate cancer.
Kapoor A, Hotte SJ. Kapoor A, et al. Can Urol Assoc J. 2016 Aug;10(7-8Suppl3):S138-S139. doi: 10.5489/cuaj.4054. Can Urol Assoc J. 2016. PMID: 27895809 Free PMC article. Review. No abstract available.
Chemotherapy research for metastatic prostate cancer.
Kapoor A, Hotte SJ. Kapoor A, et al. Can Urol Assoc J. 2016 Aug;10(7-8Suppl3):S140-S143. doi: 10.5489/cuaj.4055. Can Urol Assoc J. 2016. PMID: 27895810 Free PMC article. Review. No abstract available.
Radionuclides.
Kapoor A, Hotte SJ. Kapoor A, et al. Can Urol Assoc J. 2016 Aug;10(7-8Suppl3):S144-S145. doi: 10.5489/cuaj.4056. Can Urol Assoc J. 2016. PMID: 27895811 Free PMC article. Review. No abstract available.
Androgen receptor axis-targeted agents.
Kapoor A, Hotte SJ. Kapoor A, et al. Can Urol Assoc J. 2016 Aug;10(7-8Suppl3):S146-S148. doi: 10.5489/cuaj.4057. Can Urol Assoc J. 2016. PMID: 27895812 Free PMC article. Review. No abstract available.
First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience.
Lalani AA, Li H, Heng DYC, Wood L, Kalirai A, Bjarnason GA, Sim HW, Kollmannsberger CK, Kapoor A, Hotte SJ, Vanhuyse M, Czaykowski P, Reaume MN, Soulieres D, Venner P, North S, Basappa NS. Lalani AA, et al. Among authors: hotte sj. Can Urol Assoc J. 2017 Mar-Apr;11(3-4):112-117. doi: 10.5489/cuaj.4398. Can Urol Assoc J. 2017. PMID: 28515811 Free PMC article.
188 results